[Radioimmunoscintigraphy of colorectal cancer using the anti-CEA monoclonal antibody BW 431/26. Final results]. 1999

J Oliva, and G Pimentel, and R Peralta, and M Borrón, and R Ortiz, and J Gutiérrez, and J Guerra, and W Quesada, and R Dopico, and F Casanova, and R P Baum
Dpto. Medicina Nuclear, Instituto Nacional de Oncología y Radiobiología, C. Habana,1047, Cuba.

The anti-carcinoembryonic antigen (CEA) antibody, BW 431/26 (Scintimun CEA, Behringwerke, Marburg, Germany ) labeled with technetium pertechnectate (99mTc), is an intact immunoglobulin G1, monoclonal antibody that has been used to image colorectal cancer. Planar and SPECT images of chest, abdomen and pelvis were performed at 10 minutes, 4-6 and 18-24 hours after the intravenous antibody injection. 44 patients were studied and the pathological antibody concentration localization by radioimmunoimaging (RI) were correlated with surgical, clinical and other imaging modality findings to validate the RI. The RI was positive in 29 patients and negative in the other 15 patients. The CEA and CA 19.9 were elevated in the serum of some patients with primary tumors or recurrence. The HAMA were determined in all the patients before and after the RI.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009362 Neoplasm Metastasis The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. Metastase,Metastasis,Metastases, Neoplasm,Metastasis, Neoplasm,Neoplasm Metastases,Metastases
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D012004 Rectal Neoplasms Tumors or cancer of the RECTUM. Cancer of Rectum,Rectal Cancer,Rectal Tumors,Cancer of the Rectum,Neoplasms, Rectal,Rectum Cancer,Rectum Neoplasms,Cancer, Rectal,Cancer, Rectum,Neoplasm, Rectal,Neoplasm, Rectum,Rectal Cancers,Rectal Neoplasm,Rectal Tumor,Rectum Cancers,Rectum Neoplasm,Tumor, Rectal
D002272 Carcinoembryonic Antigen A glycoprotein that is secreted into the luminal surface of the epithelia in the gastrointestinal tract. It is found in the feces and pancreaticobiliary secretions and is used to monitor the response to colon cancer treatment. Antigens, CD66e,CD66e Antigen,Antigen, CD66e,Antigen, Carcinoembryonic,CD66e Antigens
D002277 Carcinoma A malignant neoplasm made up of epithelial cells tending to infiltrate the surrounding tissues and give rise to metastases. It is a histological type of neoplasm and not a synonym for "cancer." Carcinoma, Anaplastic,Carcinoma, Spindle-Cell,Carcinoma, Undifferentiated,Carcinomatosis,Epithelial Neoplasms, Malignant,Epithelioma,Epithelial Tumors, Malignant,Malignant Epithelial Neoplasms,Neoplasms, Malignant Epithelial,Anaplastic Carcinoma,Anaplastic Carcinomas,Carcinoma, Spindle Cell,Carcinomas,Carcinomatoses,Epithelial Neoplasm, Malignant,Epithelial Tumor, Malignant,Epitheliomas,Malignant Epithelial Neoplasm,Malignant Epithelial Tumor,Malignant Epithelial Tumors,Neoplasm, Malignant Epithelial,Spindle-Cell Carcinoma,Spindle-Cell Carcinomas,Tumor, Malignant Epithelial,Undifferentiated Carcinoma,Undifferentiated Carcinomas
D003110 Colonic Neoplasms Tumors or cancer of the COLON. Cancer of Colon,Colon Adenocarcinoma,Colon Cancer,Cancer of the Colon,Colon Neoplasms,Colonic Cancer,Neoplasms, Colonic,Adenocarcinoma, Colon,Adenocarcinomas, Colon,Cancer, Colon,Cancer, Colonic,Cancers, Colon,Cancers, Colonic,Colon Adenocarcinomas,Colon Cancers,Colon Neoplasm,Colonic Cancers,Colonic Neoplasm,Neoplasm, Colon,Neoplasm, Colonic,Neoplasms, Colon
D005069 Evaluation Studies as Topic Works about studies that determine the effectiveness or value of processes, personnel, and equipment, or the material on conducting such studies. Critique,Evaluation Indexes,Evaluation Methodology,Evaluation Report,Evaluation Research,Methodology, Evaluation,Pre-Post Tests,Qualitative Evaluation,Quantitative Evaluation,Theoretical Effectiveness,Use-Effectiveness,Critiques,Effectiveness, Theoretical,Evaluation Methodologies,Evaluation Reports,Evaluation, Qualitative,Evaluation, Quantitative,Evaluations, Qualitative,Evaluations, Quantitative,Indexes, Evaluation,Methodologies, Evaluation,Pre Post Tests,Pre-Post Test,Qualitative Evaluations,Quantitative Evaluations,Report, Evaluation,Reports, Evaluation,Research, Evaluation,Test, Pre-Post,Tests, Pre-Post,Use Effectiveness

Related Publications

J Oliva, and G Pimentel, and R Peralta, and M Borrón, and R Ortiz, and J Gutiérrez, and J Guerra, and W Quesada, and R Dopico, and F Casanova, and R P Baum
April 1992, Nuclear medicine communications,
J Oliva, and G Pimentel, and R Peralta, and M Borrón, and R Ortiz, and J Gutiérrez, and J Guerra, and W Quesada, and R Dopico, and F Casanova, and R P Baum
January 1991, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology,
J Oliva, and G Pimentel, and R Peralta, and M Borrón, and R Ortiz, and J Gutiérrez, and J Guerra, and W Quesada, and R Dopico, and F Casanova, and R P Baum
January 1993, Pathologie-biologie,
J Oliva, and G Pimentel, and R Peralta, and M Borrón, and R Ortiz, and J Gutiérrez, and J Guerra, and W Quesada, and R Dopico, and F Casanova, and R P Baum
January 1990, Acta medica Austriaca,
J Oliva, and G Pimentel, and R Peralta, and M Borrón, and R Ortiz, and J Gutiérrez, and J Guerra, and W Quesada, and R Dopico, and F Casanova, and R P Baum
December 1995, Nuklearmedizin. Nuclear medicine,
J Oliva, and G Pimentel, and R Peralta, and M Borrón, and R Ortiz, and J Gutiérrez, and J Guerra, and W Quesada, and R Dopico, and F Casanova, and R P Baum
July 1995, Cancer,
J Oliva, and G Pimentel, and R Peralta, and M Borrón, and R Ortiz, and J Gutiérrez, and J Guerra, and W Quesada, and R Dopico, and F Casanova, and R P Baum
July 1990, The British journal of cancer. Supplement,
J Oliva, and G Pimentel, and R Peralta, and M Borrón, and R Ortiz, and J Gutiérrez, and J Guerra, and W Quesada, and R Dopico, and F Casanova, and R P Baum
December 1989, Scandinavian journal of gastroenterology,
J Oliva, and G Pimentel, and R Peralta, and M Borrón, and R Ortiz, and J Gutiérrez, and J Guerra, and W Quesada, and R Dopico, and F Casanova, and R P Baum
March 1991, Medicina clinica,
J Oliva, and G Pimentel, and R Peralta, and M Borrón, and R Ortiz, and J Gutiérrez, and J Guerra, and W Quesada, and R Dopico, and F Casanova, and R P Baum
June 1996, European journal of nuclear medicine,
Copied contents to your clipboard!